Day: March 17, 2020

Piippo OyjJohtohenkilöiden liiketoimetPiippo Oyj: Johtohenkilöiden liiketoimet (Piippo)Johtohenkilöiden liiketoimet                                           17.3.2020 klo 17.45Piippo Oyj – Johdon liiketoimet____________________________________________IlmoitusvelvollinenNimi: Antti Olavi PiippoAsema: Hallituksen jäsen/varajäsenLiikkeeseenlaskija: Piippo OyjLEI: 7437002QJ697P74URL68Ilmoituksen luonne: LUOVUTUSMuutoksen selostus: Osakkeiden luovutus____________________________________________Liiketoimen päivämäärä: 2020-03-17Kauppapaikka: FIRST NORTH FINLAND (FNFI)Instrumenttityyppi: OSAKEISIN: FI4000123070Liiketoimen luonne: LUOVUTUSLiiketoimien yksityiskohtaiset tiedot(1): Volyymi: 433500 Yksikköhinta: 3,06 EURLiiketoimien yhdistetyt tiedot(1): Volyymi: 433500 Keskihinta: 3,06 EUR**PIIPPO OYJLisätietoja:Piippo Oyj, toimitusjohtaja...

Sbanken has today decided to lower its interest rates on mortgages and deposits. The bank is also significantly lowering the interest rate on bridge financing to assist customers in a particularly trying time.Following the interest rate cut from the Norwegian Central Bank (Norges Bank) on March 13, Sbanken is now lowering interest rates by up to 0.5 percentage points.– The outbreak of the Coronavirus is affecting our customers in various ways and we aim assist them as best as we can. Customers with high leveraged mortgages are among the most affected, and we have therefore decided to hand out the largest rate cuts to those with the highest loan-to-value. We have also decided to lower the interest rate to customers with bridge financing, as they represent a group facing particularly high uncertainty in the current situation, says...

Sbanken har i dag besluttet å kutte renten på lån og innskudd. På samme tid senker Sbanken også renten på mellomfinansiering for å hjelpe kunder i det som nå er en krevende tid.Med bakgrunn i det ekstraordinære rentekuttet Norges Bank gjennomførte ved i uke 11, foretar Sbanken rentekutt på inntil 0,5 prosentpoeng.– Koronasituasjonen påvirker våre kunder på ulike måter og vi ønsker å bidra i å lette på hverdagen til dem vi kan. Kunder med høy belåningsgrad på sine boliglån er blant de som situasjonen rammer verst. Med bakgrunn i det, ønsker vi å gi de høyeste rentekuttene til kundene med de høyeste belåningsgradene. Vi har også besluttet å senke renten på kunder med mellomfinansieringslån hos oss, som representerer en gruppe som nå står i en svært spesiell situasjon preget av høy usikkerhet, sier Øyvind Thomassen, daglig leder i...

Piippo OyjYhtiötiedoteSisäpiiritietoPiippo Oyj:n hallituksen jäsen Antti Olavi Piippo luopuu Piippo Oyj:n osakeomistuksestaPiippo Oyj                                         Yhtiötiedote 17.3.2020 klo 17.45Piippo Oyj:n hallituksen jäsen Antti Olavi Piippo on päättänyt tänään tehdyllä lahjoituksella luovuttaa omistamansa Piippo Oyj:n osakkeet kolmelle perilliselleen seuraavasti:Ville-Matti Piippo, 144.500 osakettaLasse Mikael Markus Piippo, 144.500 osakettaOlli-Pekka Piippo, 144.500 osakettaAntti Olavi Piippo ei tämän jälkeen omista Piippo Oyj:n osakkeita.PIIPPO OYJLisätietoja:    Piippo Oyj, toimitusjohtaja Jukka Keisanen, puh. +358 43 218 1245Hyväksytty neuvonantaja: Sisu Partners Oy, Juha Karttunen, puh. +358 40 555 4727Jakelu:          NASDAQ OMX NordicKeskeiset tiedotusvälineetwww.piippo.fiPiippo Oyj on kansainvälisesti yksi johtavista...

In view of recent events relating to the COVID–19 pandemic, it is foreseeable that the Treasury’s financing need will increase markedly from previous forecasts. The economic outlook for coming months is highly uncertain, and it is therefore difficult to estimate the Treasury’s borrowing need for the current year. It is also uncertain how much of that need will be for short-term borrowing and how much for long-term borrowing.It should be noted that Iceland’s Government debt level is low. Total debt amounts to about 854 b.kr., or roughly 27.5% of GDP. No domestic issues are scheduled to mature for the remainder of 2020, and foreign maturities total only 292 million euros (45 b.kr.), due in July.The Treasury can obtain market financing in a number of ways. It can issue more bonds in the domestic market, as issuance according to the 2020...

Í ljósi atburða síðustu vikna í tengslum við Covid-19 er fyrirsjáanlegt að fjárþörf ríkissjóðs mun aukast umtalsvert frá fyrri spám.  Mikil óvissa er um efnahagshorfur næstu mánuði og því er erfitt að meta lánsfjárþörf ríkissjóðs fyrir yfirstandandi ár. Einnig er óljóst hversu mikil þörfin verður annars vegar til skemmri tíma og hins vegar til lengri tíma.Rétt er að hafa í huga að skuldastaða ríkissjóðs er lág. Heildarskuldir eru um 854 ma.kr. sem nemur um 27,5% af vergri landsframleiðslu. Engin innlend ríkisbréfaútgáfa er á gjalddaga það sem eftir lifir ársins og einungis 292 milljónir evra (45 ma.kr.) er á gjalddaga í júlí.Ríkissjóður hefur ýmsar leiðir til þess að sækja fjármagn á markaði. Hægt er að auka útgáfu ríkisbréfa á innlendum markaði en útgáfa samkvæmt ársáætlun fyrir yfirstandandi ár er nú við sögulegt lágmark eða um 40 ma.kr....

TORONTO, March 17, 2020 (GLOBE NEWSWIRE) — Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that it has safely completed dosing of the final eight healthy volunteers in its Phase I human trial of Metablok (LSALT peptide). This final group received the highest daily dose of Metablok tested to date for three consecutive days and met the primary endpoints of safety and tolerability. Metablok is the Company’s lead drug candidate for treating inflammation in the lungs, liver and kidneys.The completion of the Phase I trial can now be followed by Phase II studies to investigate Metablok’s efficacy at preventing inflammation in a vital organ. Arch has been considering targeting inflammation related acute kidney injury in patients undergoing cardiac surgery and/or a separate trial to target...

3D BioMed test demonstrated 99.3% sensitivity and 100% specificity in Chinese clinical trial Nucleic Acid test performed on proprietary automated platform to increase throughput CE Mark and Chinese FDA approval have been received; 3D BioMed in discussions with US FDA Technology was deployed in Wuhan, China with over 100,000 tests completed Combination coronavirus and influenza A/B testing novel among PCR approachesREHOVOT, Israel and New York, NY, March 17, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Todos Medical Ltd. (TOMDF), a pre-commercial stage in-vitro-diagnostics company focused on the development of blood tests for the early detection of cancer and neurodegenerative disorders, today announced that it has entered into a non-exclusive distribution agreement with 3D Biomedicine Science & Technology Co., a China-based...

Bergen, 17 March 2020: Given the ongoing COVID-19 outbreak, Grieg Seafood Group ASA (the “Company” or “GSF” with OSE ticker: “GSF”) would like to provide an update on the impact on its business and organization. Grieg Seafood’s operations are currently, in light of the circumstances, running as normal.Organization and employeesGrieg Seafood’s priority is the wellbeing of its employees, their families and the local communities where we operate, and the Company complies fully with the authorities’ recommendations in all locations.The Company has implemented measures to limit contamination, with crises management teams operating in the head office and in each region. The regions have conducted local risk assessments and implemented measures accordingly, such as limiting contact between shifts, hygiene...

Stian Lønvik, CFO and primary insider of NORBIT ASA has on 17 March 2020 purchased 2,000 shares in NORBIT at an average price of NOK 15.51 per share.Following the transaction, Lønvik owns 176,389 shares, representing 0.31 per cent of the outstanding shares in NORBIT. Most of the shares are owned through the company Loen Holding AS, which Lønvik owns with his wife, Camilla N. LønvikFor more information, please contact:Charlotte Knudsen, IR and Communications, +47 9756 1959About NORBIT ASANORBIT is a global provider of tailored technology to carefully selected niches. The company’s business is structured to address its key markets; Oceans, targeting the global maritime markets, Intelligent Traffic Systems (ITS), offering connectivity solutions for truck applications, and Product Innovation and Realization (PIR), with in-house multidisciplinary...